UBS Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $134M | Buy |
|
|||||
|
2023
Q3 | $501K | Sell |
|
|||||
|
2023
Q2 | $3.58M | Sell |
|
|||||
|
2023
Q1 | $4.59M | Buy |
|
|||||
|
2022
Q4 | $4.79M | Buy |
|
|||||
|
2022
Q3 | $833K | Sell |
|
|||||
|
2022
Q2 | $1.26M | Sell |
|
|||||
|
2022
Q1 | $3.8M | Buy |
|
|||||
|
2021
Q4 | $230K | Sell |
|
|||||
|
2021
Q3 | $2.9M | Buy |
|
|||||
|
2021
Q2 | $70K | Sell |
|
|||||
|
2021
Q1 | $600K | Buy |
|
|||||
|
2020
Q4 | $72K | Sell |
|
|||||
|
2020
Q3 | $61K | Sell |
|
|||||
|
2020
Q2 | $271K | Buy |
|
|||||
|
2020
Q1 | $149K | Sell |
|
|||||
|
2019
Q4 | $223K | Sell |
|
|||||
|
2019
Q3 | $57K | Buy |
|